ReviewEClinicalMedicine2025
Clinical features of Marburg virus disease: a review of all reported patients since 1967.
Review in EClinicalMedicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed.
- Epidemiology and containment of the first Marburg virus disease outbreak in Ethiopia in 2025: A retrospective descriptive study.Global epidemiology · 2026Article
- Marburg virus disease outbreak and response in South Ethiopia Region.International journal of emergency medicine · 2026Article
- Histologic atlas of the Egyptian rousette (Rousettus aegyptiacus) with an integrated review of macroscopic anatomy.Veterinary research · 2026Review
- Integrative reverse vaccinology and computational modeling for the rational design of a broadly immunogenic multi-epitope vaccine against Marburg virus infection.Naunyn-Schmiedeberg's archives of pharmacology · 2026Article
- Emerging Viral Zoonoses: Epidemiology, Vaccination Strategies, and Implications for Global Public Health.Vaccines · 2026Review
- Perceptions, Preparedness, and Anticipated Challenges of Healthcare Workers and Communities for Potential Marburg virus outbreaks in South Omo, Southern Ethiopia, 2025: a qualitative case study.BMC public health · 2026Article
- Achievements and Challenges in Therapy and Vaccines Development of Viral Hemorrhagic Fevers: An Up-to-Date Review.Pharmaceutics · 2026Review
- Beyond global North-led response: South-South collaboration at the frontline of Marburg virus outbreak control.PLOS global public health · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Background: Marburg virus disease (MVD) is a severe and often fatal illness caused by the Marburg or Ravn virus. Given the remote areas affected and the infrequency of the disease, the MVD presenting syndromes are unclear, and this may limit timely recognition. Methods: We conducted 333 a literature review of published case reports and outbreak investigations from January 1st, 1967 to October 30th, 2024, to describe the prevalence of MVD-associated symptoms and syndromes. Findings: 722 cases of MVD occurred across 18 outbreaks, with detailed clinical data available for 325 cases. Common symptoms include fever, headache, fatigue, and myalgia; gastrointestinal symptoms are also frequently reported. Haemorrhagic symptoms, mainly hematemesis and bloody diarrhoea, are more specific but less frequent. The overall lethality rate is 72% (95% CI: 68.8-75.0%), dropping to 44% (95% CI: 37.1-50.9%) among PCR-confirmed cases. Interpretation: Variability in prevalent symptoms across different outbreaks complicates early recognition. The lower lethality observed in PCR-confirmed cases may reflect earlier access to appropriate care once Marburg virus disease was recognized, as well as potential misclassification of non-MVD febrile illnesses among unconfirmed cases. Funding: This work was supported by the Italian Ministry of Health, Project P3 - Ricerca Corrente Linea1 - Malattie infettive tropicali e neglette: aspetti patogeneteci, immunologici e diagnostici del Ministero della salute-INMI L.Spallanzani I.R.C.C.S.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.